Idioma: Inglés
Publicado por Bentham Science Publishers, 2025
ISBN 10: 9815274783 ISBN 13: 9789815274783
Librería: California Books, Miami, FL, Estados Unidos de America
EUR 78,09
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Amazon Digital Services LLC - Kdp, 2025
ISBN 10: 9815274783 ISBN 13: 9789815274783
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 79,58
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Amazon Digital Services LLC - Kdp, 2025
ISBN 10: 9815274783 ISBN 13: 9789815274783
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 74,75
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Bentham Science Publishers Singapore Pte. Ltd., 2025
ISBN 10: 9815274783 ISBN 13: 9789815274783
Librería: CitiRetail, Stevenage, Reino Unido
EUR 80,99
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. Intellectual Property Rights Issues in Vaccine Development offers a timely exploration of the evolving role of intellectual property (IP) in shaping global vaccine research, innovation, and accessibility. As the world continues to grapple with public health challenges like the COVID-19 pandemic- this book provides a critical lens on how patents, trade secrets, and international agreements influence vaccine development and distribution. The contents of the book explore the historical evolution of IP in vaccinology, the debate over patent protection, the intersection of legal frameworks and ethical concerns, and the tension between innovation and equitable access. Special attention is given to global case studies, the impact of international agreements, and recommendations for stakeholders across policy, industry, and healthcare sectors. Key features: -Traces the history and legal evolution of vaccine-related IP -Analyzes global access challenges and equity concerns -Explores the role of IP during the COVID-19 pandemic -Examines real-world case studies of vaccine IP dynamics -Offers actionable policy and industry recommendations This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.